While excipients stay low-risk, FDA inspection policy will stay business as usual. (Excipients).: An article from: Validation Times

This digital document is an article from Validation Times, published by Washington Information Source on September 1, 2002. The length of the article is 661 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: While excipients stay low-risk, FDA inspection policy will stay business as usual. (Excipients).
Author: Kelly Huegel
Publication:Validation Times (Newsletter)
Date: September 1, 2002
Publisher: Washington Information Source
Volume: 4 Issue: 9 Page: 2

Distributed by Thomson Gale